Quantbot Technologies LP bought a new position in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 25,061 shares of the company's stock, valued at approximately $345,000.
Several other large investors have also added to or reduced their stakes in ARDT. Point72 Asia Singapore Pte. Ltd. bought a new stake in Ardent Health during the fourth quarter worth $27,000. Morse Asset Management Inc acquired a new position in shares of Ardent Health in the first quarter valued at about $36,000. Deutsche Bank AG grew its stake in Ardent Health by 1,251.9% during the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after buying an additional 2,654 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in Ardent Health during the first quarter worth about $142,000. Finally, Beacon Capital Management LLC acquired a new stake in Ardent Health during the first quarter worth about $144,000.
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. Stephens reiterated an "overweight" rating and issued a $21.00 price objective on shares of Ardent Health in a report on Tuesday, May 20th. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. KeyCorp decreased their price target on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. JPMorgan Chase & Co. cut their price objective on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $21.00 price target on shares of Ardent Health in a report on Thursday, May 15th. Eight equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.56.
Get Our Latest Stock Report on Ardent Health
Ardent Health Stock Down 0.9%
Shares of NYSE ARDT opened at $12.58 on Wednesday. Ardent Health, Inc. has a 12 month low of $10.10 and a 12 month high of $20.72. The firm has a fifty day simple moving average of $12.40 and a two-hundred day simple moving average of $13.28. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.80 billion and a PE ratio of 6.95.
Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%.The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Equities analysts expect that Ardent Health, Inc. will post 1.23 earnings per share for the current year.
Ardent Health Profile
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.